Allstate Corp Bio Techne Corp Transaction History

Allstate Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $482,648 - $2.11 Million	5,983 Added 318.75%	7,860 $651,000
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $54,530 - $75,627	193 Added 11.46%	1,877 $533,000
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $543,376 - $757,210	1,684 New	1,684 $584,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.96B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.